Phase I combination study of trabectedin (T) and capecitabine (C) in patients with advanced malignancies

2079 Background: T binds to the minor groove of DNA, synergizes with functional nuclease excision repair and targets inducible transcription. T is active in several tumor types and exhibits preclin...